Effect Of Mifepristone on Serum Progesterone Level and Modified Bishop Score in Induction of Labour at A Tertiary Care Centre in Bihar
Keywords:
Mifepristone, Cervical Ripening, Induction of Labour, Modified Bishop’s Score, Serum ProgesteroneAbstract
Background: Induction of labour is a pivotal intervention in obstetric practice, aimed at facilitating a safe and timely vaginal delivery. A favourable or "ripe" cervix is a fundamental prerequisite for its success. The present study aimed to evaluate the efficacy of oral mifepristone in inducing labour by examining its effect on cervical ripening, as measured by changes in the Modified Bishop’s score, and its impact on serum progesterone levels.
Materials and Methods: This was a case-control study conducted at the Department of Obstetrics and Gynaecology at Indira Gandhi Institute of Medical Sciences, Patna, Bihar (India), for a duration of 1.5 years. A total of 220 participants fulfilling the inclusion criteria were divided into 2 groups: Group A (Case) with Bishop’s score <3 received 200 mg oral mifepristone and Group B (control) presented with spontaneous labour pain with cervical dilatation <3 cm. Change in Modified Bishop’s score and serum Progesterone levels were assessed 48 hours after administering Mifepristone or at the onset of established labour in Group A. In Group B, Modified Bishop’s score and serum progesterone measurement were done at the time of admission. Both groups were compared in terms of change in serum progesterone levels, number of patient’s went into active labour, mode of deliveries, indications of LSCS, and neonatal outcomes.
Results: In the case group, mean Bishop Score significantly increased from 2.98 at the time of admission to 6.69 at 48 hours or onset of labor (p < 0.001), and the mean (SD) change in serum progesterone at 48 hours or onset of labor was -28.02 (22.90) ng/mL. There was a significant difference between the two groups in terms of serum progesterone level (48 hours/onset of labour) (t=-3.946, p=<0.001), with the mean serum progesterone level being highest in the control group. There was no significant difference between the 2 groups in terms of the number of patients who went into active labour, mode of deliveries, Indications of LSCS, and neonatal outcomes.
Conclusion: Mifepristone significantly enhances cervical ripening as evidenced by significant changes in Bishop scores, and lowers serum progesterone levels in a clinically relevant timeframe and shortened labor intervals without increasing maternal or neonatal risk. Hence, mifepristone is a valuable adjunct in obstetric practice, especially for women requiring cervical ripening and induction of labor..
Downloads
Metrics
References
Misra R. Ian Donald’s Practical Obstetrics Problems, 9 ed. Wolters Kluwer India Pvt Ltd; 2020.
Csapo A. THE ONSET OF LABOUR. The Lancet [Internet]. 2003 Aug 4;278(7197):277–80.
Thiripurasundari S, Minnalkodi S. To Determine The Effect of Tablet Mifepristone In Induction of Labour In Term Pregnancy In Indian Population. Frontiers in Health Informatics. 2024 Oct 1;13(7).
Amrutha. A.V., Shaila C, Ravi Karad. Comparative Study of Efficacy and Safety of Mifepristone and Foley’s Catheter in Induction of Labour. International Journal of Science and Research. 2021 June;10(6) : 1537-41. DOI: 10.21275/SR21624174210.
Vidya Gaikwad, Bilsi Mittal, and Mangal Puri. Comparative Analysis of Safety, Efficacy and Fetomaternal Outcome of Induction of Labour with Mifepristone versus Intracervical Dinoprostone Gel. Research Journal of Pharmaceutical, Biological and Chemical Sciences.2014;5(2):611-16.
Sharma C, Soni A, Soni PK, Verma S, Verma A, Gupta A. A retrospective case–control study evaluating the role of mifepristone for induction of labor in women with previous cesarean section. The Journal of Obstetrics and Gynecology of India. 2016 Oct;66:30-7.
Baev O, Karapetian A, Babich D, Sukhikh G. Comparison of outpatient with inpatient mifepristone usage for cervical ripening: a randomised controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology: X. 2023 Jun 1;18:100198.
Thakur V, Kamal D, Ramaraju HE, Chawla S. Effect of Oral Mifepristone on Modified Bishop's Score in Term Pregnancy. J Obstet Gynaecol India. 2024 Jun;74(3):219-223. doi: 10.1007/s13224-023-01875-4.
Pharande P, Kiran AR, Patel S, Vanrajsinh HV. Safety and Efficacy of Oral Mifepristone for Cervical Ripening and Induction of Labor. Cureus. 2024 Jul 26;16(7):e65450. doi: 10.7759/cureus.65450.
Csapo AI, Pulkkinen M. The role of progesterone in the regulation of parturition. Biol Reprod. 1978;18(1):59–80.
Frydman R, Fernandez H. Parturition induction with the progesterone antagonist RU 486. J Gynecol Obstet Biol Reprod (Paris). 1990;19(4):500-505.
Heikinheimo O, Kekkonen R, Lähteenmäki P. Dose-response relationships of RU 486. Clin Endocrinol (Oxf). 1989;31(5):591–599.
Stenlund PM, Nylund LE, Hamberger L. Induction of labor with mifepristone—a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand. 1999;78(9):793–798.
Hapangama D, Neilson JP. Mifepristone for induction of labour. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD002865. DOI: 10.1002/14651858. CD002865.pub2. Accessed 29 May 2025.
Li L, Gao W, Chen S. Efficacy and safety of mifepristone for labor induction in term pregnancy: A meta-analysis. J Perinat Med. 2019;47(6):644-652.
Buser TF, Arias F. Mifepristone for premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 1991;41(2):133-139.
Boipai P, Sinha T, Kumari S, Kumari P, Sharma A, Trivedi K. Role of Mifepristone in Induction of Labor in Full-Term Pregnancy. Cureus. 2024 Oct 16;16(10):e71632. doi: 10.7759/cureus.71632. PMID: 39553130; PMCID: PMC11566946.
Gomathy E, Neha B S. A prospective study to compare oral mifepristone and dinoprostone gel in induction of labour in primigravida. Indian J Obstet Gynecol Res 2022;9(2):204-207.
Baev OR, Rumyantseva VP, Tysyachnyu OV, Kozlova OA, Sukhikh GT. Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2017 Oct; 217:144-149. doi: 10.1016/j.ejogrb.2017.08.038.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
